Delphinidin reduces cell proliferation and induces apoptosis of non-small-cell lung cancer cells by targeting EGFR/VEGFR2 signaling pathways. [electronic resource]
Producer: 20140522Description: e77270 p. digitalISSN:- 1932-6203
- Animals
- Anthocyanins -- administration & dosage
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Apoptosis -- drug effects
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Caspases -- metabolism
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cyclin D1 -- metabolism
- Disease Models, Animal
- Epidermal Growth Factor -- pharmacology
- ErbB Receptors -- metabolism
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Mice
- Mitogen-Activated Protein Kinases -- metabolism
- Neovascularization, Pathologic -- drug therapy
- Phosphatidylinositol 3-Kinases -- metabolism
- Phosphorylation -- drug effects
- Poly(ADP-ribose) Polymerases -- metabolism
- Proliferating Cell Nuclear Antigen -- metabolism
- Proteolysis -- drug effects
- Proto-Oncogene Proteins c-akt -- metabolism
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- Signal Transduction -- drug effects
- Tumor Burden -- drug effects
- Vascular Endothelial Growth Factor A -- pharmacology
- Vascular Endothelial Growth Factor Receptor-2 -- metabolism
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.